Guardian Pharmacy Services Inc: 16 Cents Per Action Profit
- (GRDN) is scheduled to release its financial results on march 26, covering the period ending December 31, 2024.
- According to LSEG data, a consensus of three analysts estimates the Atlanta, Georgia-based company will report revenue of $332.77 million.
- LSEG analysts predict an average profit of 16 cents per share for Guardian Pharmacy Services Inc.
Guardian Pharmacy services Inc. to Report Earnings March 26
Table of Contents
- Guardian Pharmacy services Inc. to Report Earnings March 26
- Guardian pharmacy Services Inc. Earnings Q&A: What Investors Need to Know
- When will Guardian Pharmacy Services Inc. (GRDN) release its earnings report?
- What are analysts’ expectations for Guardian Pharmacy services Inc.’s revenue?
- What is the expected profit per share for Guardian Pharmacy Services Inc.?
- What is the current analyst rating for Guardian Pharmacy Services Inc. (GRDN)?
- How have analysts’ profit estimates changed over time?
- What is the price target for Guardian Pharmacy Services Inc. (GRDN)?
- How did Guardian Pharmacy Services Inc. perform in the previous quarter?
Analysts anticipate revenue of $332.77 million.
Guardian Pharmacy Services Inc. (GRDN) is scheduled to release its financial results on march 26, covering the period ending December 31, 2024.
According to LSEG data, a consensus of three analysts estimates the Atlanta, Georgia-based company will report revenue of $332.77 million.
LSEG analysts predict an average profit of 16 cents per share for Guardian Pharmacy Services Inc.
The current consensus among analysts is a “buy” rating, with recommendations distributed as three “strong buy” or “buy” ratings. Ther are no “hold,” “sell,” or “strong sell” recommendations.
The average estimate for analysts’ profits has remained consistent over the past three months.
The median price target from Wall Street analysts for Guardian Pharmacy Services inc. is $24.00, exceeding the last closing price of $21.35.
Previous Quarterly Performance (USD)
| End of Quarter | Starminesmartestimate® | Ibes Estimate | Actual | Result | Surprise % |
|---|---|---|---|---|---|
| Sept. 30, 2024 | 0.19 | 0.19 | -2.00 | Failure | -1,152.6 |
| 2024 |
Guardian pharmacy Services Inc. Earnings Q&A: What Investors Need to Know
When will Guardian Pharmacy Services Inc. (GRDN) release its earnings report?
Guardian Pharmacy Services Inc. (GRDN) is scheduled to unveil its financial results on March 26th. This report will cover the period ending December 31, 2024.
What are analysts’ expectations for Guardian Pharmacy services Inc.’s revenue?
Analysts, based on data from LSEG, anticipate that Guardian Pharmacy Services Inc. will report revenue of $332.77 million.
LSEG analysts predict an average profit of 16 cents per share for Guardian Pharmacy Services Inc.
What is the current analyst rating for Guardian Pharmacy Services Inc. (GRDN)?
the current consensus among analysts is a “buy” rating for Guardian Pharmacy Services Inc. This is based on recommendations that include three “strong buy” or “buy” ratings. There are no “hold,” “sell,” or “strong sell” recommendations.
How have analysts’ profit estimates changed over time?
The average estimate for analysts’ profits has remained consistent over the past three months.
What is the price target for Guardian Pharmacy Services Inc. (GRDN)?
The median price target from Wall Street analysts for Guardian Pharmacy Services Inc. is $24.00. This figure exceeds the last closing price of $21.35.
How did Guardian Pharmacy Services Inc. perform in the previous quarter?
Here’s a summary of the previous quarterly performance:
| End of Quarter | starminesmartestimate® | Ibes Estimate | Actual | Result | Surprise % |
|—|—|—|—|—|—|
| Sept. 30, 2024 | 0.19 | 0.19 | -2.00 | Failure | -1,152.6 |
| 2024 | | | | | |